2016
DOI: 10.1111/bjd.14345
|View full text |Cite
|
Sign up to set email alerts
|

Photodynamic therapy with methyl aminolaevulinate 80 mg g−1for severe facial acne vulgaris: a randomized vehicle-controlled study

Abstract: PDT using topical MAL 80 mg g(-1) and red light may offer promise for severe acne vulgaris.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

3
35
0
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 36 publications
(39 citation statements)
references
References 22 publications
3
35
0
1
Order By: Relevance
“…The clinical aspect of the reaction was similar to a hypertrophic AK associated with an infective affection. Considering the well-known utility of ALA-PDT in the doi: 10.18282/jsd.v1.i1.36 treatment of both AK and infective diseases, we applied it on the patient's skin in order to solve the severe local reaction [5] . We observed a complete resolution just after two sessions of PDT.…”
Section: Resultsmentioning
confidence: 99%
“…The clinical aspect of the reaction was similar to a hypertrophic AK associated with an infective affection. Considering the well-known utility of ALA-PDT in the doi: 10.18282/jsd.v1.i1.36 treatment of both AK and infective diseases, we applied it on the patient's skin in order to solve the severe local reaction [5] . We observed a complete resolution just after two sessions of PDT.…”
Section: Resultsmentioning
confidence: 99%
“…These ROS then cause sebaceous gland damage and destruction of P. acnes . MAL, which is a commonly used photosensitizer outside of the US, has also been used in PDT for acne treatment and has demonstrated significant efficacy in decreasing ILC [146]. PDT shows great promise in treating acne ranging from mild to severe, but the optimal choice of photosensitizer and light source are topics still under investigation [19].…”
Section: Discussionmentioning
confidence: 99%
“…Pariser et al . conducted a double‐blind, randomized, vehicle‐controlled multicenter trial in 153 patients (age range 12–36 years; median 17) with MAL‐PDT. Fifty‐nine of those treated were children.…”
Section: Methodsmentioning
confidence: 99%